Shingles Vaccine Market Set to Reach US$27.9 Billion by 2036
The global shingles vaccine market is estimated at US$6.27 billion in 2026 and is projected to reach US$27.9 billion by 2036, expanding at a 16.1% CAGR, according to Fact.MR analysis. The market is expected to create an absolute dollar opportunity of US$21.63 billion during the 2026–2036 period as adult immunization programs expand across major healthcare systems. The growth outlook is...
0 Commentaires 0 Parts 8 Vue 0 Aperçu